These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 27903989)
1. Repression of YAP by NCTD disrupts NSCLC progression. Guo J; Wu Y; Yang L; Du J; Gong K; Chen W; Dai J; Li X; Xi S Oncotarget; 2017 Jan; 8(2):2307-2319. PubMed ID: 27903989 [TBL] [Abstract][Full Text] [Related]
2. Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non‑small lung cancer cells by regulating the YAP pathway. Jin D; Wu Y; Shao C; Gao Y; Wang D; Guo J Oncol Rep; 2018 Aug; 40(2):609-620. PubMed ID: 29901163 [TBL] [Abstract][Full Text] [Related]
3. Suppression of YAP by DDP disrupts colon tumor progression. Li K; Guo J; Wu Y; Jin D; Jiang H; Liu C; Qin C Oncol Rep; 2018 May; 39(5):2114-2126. PubMed ID: 29512779 [TBL] [Abstract][Full Text] [Related]
4. Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer. Xie J; Zhang Y; Hu X; Lv R; Xiao D; Jiang L; Bao Q Med Oncol; 2015 May; 32(5):145. PubMed ID: 25814287 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway. Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256 [TBL] [Abstract][Full Text] [Related]
6. RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway. Dubois F; Keller M; Calvayrac O; Soncin F; Hoa L; Hergovich A; Parrini MC; Mazières J; Vaisse-Lesteven M; Camonis J; Levallet G; Zalcman G Cancer Res; 2016 Mar; 76(6):1627-40. PubMed ID: 26759237 [TBL] [Abstract][Full Text] [Related]
7. The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC. Jin D; Guo J; Wang D; Wu Y; Wang X; Gao Y; Shao C; Xu X; Tan S EBioMedicine; 2018 Nov; 37():188-204. PubMed ID: 30389502 [TBL] [Abstract][Full Text] [Related]
8. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer. Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834 [TBL] [Abstract][Full Text] [Related]
9. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
10. Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway. Peng C; Li Z; Niu Z; Niu W; Xu Z; Gao H; Niu W; Wang J; He Z; Gao C; Lin P; Agrez M; Zhang Z; Niu J Sci Rep; 2016 Feb; 6():20500. PubMed ID: 26846153 [TBL] [Abstract][Full Text] [Related]
11. YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin. Zhang W; Gao Y; Li F; Tong X; Ren Y; Han X; Yao S; Long F; Yang Z; Fan H; Zhang L; Ji H Cancer Res; 2015 Nov; 75(21):4450-7. PubMed ID: 26363011 [TBL] [Abstract][Full Text] [Related]
12. Radiation-induced YAP/TEAD4 binding confers non-small cell lung cancer radioresistance via promoting NRP1 transcription. Wang M; Yi J; Gao H; Wei X; Xu W; Zhao M; Zhao M; Shen Y; Wang Z; Wu N; Wei W; Jin S Cell Death Dis; 2024 Aug; 15(8):619. PubMed ID: 39187525 [TBL] [Abstract][Full Text] [Related]
13. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer. Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398 [TBL] [Abstract][Full Text] [Related]
14. Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling. Wang H; Lu B; Castillo J; Zhang Y; Yang Z; McAllister G; Lindeman A; Reece-Hoyes J; Tallarico J; Russ C; Hoffman G; Xu W; Schirle M; Cong F J Biol Chem; 2016 Jul; 291(29):15256-66. PubMed ID: 27231341 [TBL] [Abstract][Full Text] [Related]
15. MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer. Lo Sardo F; Forcato M; Sacconi A; Capaci V; Zanconato F; Di Agostino S; Del Sal G; Pandolfi PP; Strano S; Bicciato S; Blandino G Carcinogenesis; 2017 Jan; 38(1):64-75. PubMed ID: 27797825 [TBL] [Abstract][Full Text] [Related]
16. Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model. Hsu PC; Tian B; Yang YL; Wang YC; Liu S; Urisman A; Yang CT; Xu Z; Jablons DM; You L Oncol Rep; 2019 Aug; 42(2):697-707. PubMed ID: 31233205 [TBL] [Abstract][Full Text] [Related]
17. Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway. Wu D; Zhao B; Qi X; Peng F; Fu H; Chi X; Miao QR; Shao S Cancer Lett; 2018 Apr; 418():135-146. PubMed ID: 29331415 [TBL] [Abstract][Full Text] [Related]
18. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma. Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164 [TBL] [Abstract][Full Text] [Related]
19. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD. Yu M; Chen Y; Li X; Yang R; Zhang L; Huangfu L; Zheng N; Zhao X; Lv L; Hong Y; Liang H; Shan H Cell Death Dis; 2018 May; 9(5):464. PubMed ID: 29700328 [TBL] [Abstract][Full Text] [Related]
20. MiR-4319 hinders YAP expression to restrain non-small cell lung cancer growth through regulation of LIN28-mediated RFX5 stability. Yang Y; Li H; Liu Y; Chi C; Ni J; Lin X Biomed Pharmacother; 2019 Jul; 115():108956. PubMed ID: 31096145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]